Global Small Interfering RNA (siRNA) Therapeutics Market Insight 2020, Forecast to 2030
- Report Code : WOR2005365
- Published On: Aug, 2020
- Category : Healthcare & Pharma
- Pages : 166
-
The Small Interfering RNA (siRNA) Therapeutics market was valued at US$ xx in 2019, prior to COVID-19. Whereas post-COVID-19 scenario, the market for Small Interfering RNA (siRNA) Therapeutics is projected to grow from US$ xx million in 2020, and is projected to reach xx by 2025, at a CAGR of xx% during the forecast period. Projected and forecast revenue values are in constant U.S. dollars, unadjusted for inflation. Product values are estimated based on manufacturers' revenue.
The report offers detailed coverage of Small Interfering RNA (siRNA) Therapeutics industry and main market trends. The market research includes historical and forecast market data, demand, application details, price trends, and company shares of the leading Small Interfering RNA (siRNA) Therapeutics by geography. The report splits the market size, by volume and value, on the basis of application type and geography.
In addition to this data, the report provides insight into drivers of market demand and strategies of suppliers. Key players are profiled, and their market shares in the global Small Interfering RNA (siRNA) Therapeutics market are discussed.
The market is segmented by types:
Liposome Based Systemic Therapy
Nanoparticle Based Systemic Therapy
Other
It can be also divided by applications:
Hospital
Research Institutions
Pharmaceutical and Biotechnology Companies
Academic Institutions
Other
And this report covers the historical situation, present status and the future prospects of the global Small Interfering RNA (siRNA) Therapeutics market for 2015-2025. In this report, we analyze global market from 5 geographies: Asia-Pacific, Europe, North America, Middle East & Africa, South America.
Finally, the report provides detailed profile and data information analysis of leading company.
GE
Horizon Discovery
Thermo Scientific
OPKO Health
AInylam Pharmaceuticals
Arrowhead Research
Sanofi Genzyme
Genecon Biotechnologies
Arbutus Biopharma
Silent Therapeutics
Sylentis
Report Includes:
- xx data tables and xx additional tables
- An overview of global Small Interfering RNA (siRNA) Therapeutics market
- An detailed key players analysis across regions
- Analyses of global market trends, with historical data, estimates for 2020 and projections of compound annual growth rates (CAGRs) through 2025
- Insights into regulatory and environmental developments
- Information on the supply and demand scenario and evaluation of technological and investment opportunities in the Small Interfering RNA (siRNA) Therapeutics market
- Profiles of major players in the industry, including GE, Horizon Discovery, Thermo Scientific, OPKO Health, AInylam Pharmaceuticals..
Research Objectives
To study and analyze the global Small Interfering RNA (siRNA) Therapeutics consumption (value & volume) by key regions/countries, product type and application, history data from 2015 to 2019, and forecast to 2025.
To understand the structure of Small Interfering RNA (siRNA) Therapeutics market by identifying its various subsegments.
Focuses on the key global Small Interfering RNA (siRNA) Therapeutics manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, Porter's five forces analysis, SWOT analysis and development plans in next few years.
To analyze the Small Interfering RNA (siRNA) Therapeutics with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Small Interfering RNA (siRNA) Therapeutics submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
-
With tables and figures helping analyze worldwide Global Small Interfering RNA (siRNA) Therapeutics market, this research provides key statistics on the state of the industry and is a valuable source of guidance and direction for companies and individuals interested in the market.
Global Small Interfering RNA (siRNA) Therapeutics Market Report 2020, Forecast to 2025
1 Scope of the Study1.1 Small Interfering RNA (siRNA) Therapeutics Introduction
1.2 Research Programs
1.3 Analysis of Macroeconomic Indicators
1.4 Years Considered
1.5 Methodology
1.6 Data Source
1.7 Research Objectives
2 Small Interfering RNA (siRNA) Therapeutics Industry Overview2.1 Global Small Interfering RNA (siRNA) Therapeutics Market Size (Million USD) Comparison by Regions (2020-2025)
2.1.1 Small Interfering RNA (siRNA) Therapeutics Global Import Market Analysis
2.1.2 Small Interfering RNA (siRNA) Therapeutics Global Export Market Analysis
2.1.3 Small Interfering RNA (siRNA) Therapeutics Global Main Region Market Analysis2.2 Market Analysis by Type
2.2.1 Liposome Based Systemic Therapy
2.2.2 Nanoparticle Based Systemic Therapy
2.2.3 Other2.3 Market Analysis by Application
2.3.1 Hospital
2.3.2 Research Institutions
2.3.3 Pharmaceutical and Biotechnology Companies
2.3.4 Academic Institutions
2.3.5 Other2.4 Global Small Interfering RNA (siRNA) Therapeutics Revenue, Sales and Market Share by Manufacturer
2.4.1 Global Small Interfering RNA (siRNA) Therapeutics Sales and Market Share by Manufacturer (2018-2020)
2.4.2 Global Small Interfering RNA (siRNA) Therapeutics Revenue and Market Share by Manufacturer (2018-2020)
2.4.3 Global Small Interfering RNA (siRNA) Therapeutics Industry Concentration Ratio (CR5 and HHI)
2.4.4 Top 5 Small Interfering RNA (siRNA) Therapeutics Manufacturer Market Share
2.4.5 Top 10 Small Interfering RNA (siRNA) Therapeutics Manufacturer Market Share
2.4.6 Date of Key Manufacturers Enter into Small Interfering RNA (siRNA) Therapeutics Market
2.4.7 Key Manufacturers Small Interfering RNA (siRNA) Therapeutics Product Offered
2.4.8 Mergers & Acquisitions Planning2.5 Small Interfering RNA (siRNA) Therapeutics Historical Development Overview
2.6 Market Dynamics
2.6.1 Market Opportunities
2.6.2 Market Risk
2.6.3 Market Driving Force
2.6.4 Porter's Five Forces Analysis
2.7 Coronavirus Disease 2019 (Covid-19): Small Interfering RNA (siRNA) Therapeutics Industry Impact
2.7.1 How the Covid-19 is Affecting the Small Interfering RNA (siRNA) Therapeutics Industry
2.7.2 Small Interfering RNA (siRNA) Therapeutics Business Impact Assessment - Covid-19
2.7.3 Market Trends and Small Interfering RNA (siRNA) Therapeutics Potential Opportunities in the COVID-19 Landscape
2.7.4 Measures / Proposal against Covid-19
3 Upstream and Downstream Market Analysis3.1 Upstream Analysis
3.1.1 Macro Analysis of Upstream Markets
3.1.2 Key Players in Upstream Markets
3.1.3 Upstream Market Trend Analysis
3.1.4 Small Interfering RNA (siRNA) Therapeutics Manufacturing Cost Analysis3.2 Downstream Market Analysis
3.2.1 Macro Analysis of Down Markets
3.2.2 Key Players in Down Markets
3.2.3 Downstream Market Trend Analysis
3.2.4 Sales Channel, Distributors, Traders and Dealers
4 Global Small Interfering RNA (siRNA) Therapeutics Market Size Categorized by Regions4.1 Global Small Interfering RNA (siRNA) Therapeutics Revenue, Sales and Market Share by Regions
4.1.1 Global Small Interfering RNA (siRNA) Therapeutics Sales and Market Share by Regions (2015-2020)
4.1.2 Global Small Interfering RNA (siRNA) Therapeutics Revenue and Market Share by Regions (2015-2020)4.2 Europe Small Interfering RNA (siRNA) Therapeutics Sales and Growth Rate (2015-2020)
4.3 APAC Small Interfering RNA (siRNA) Therapeutics Sales and Growth Rate (2015-2020)
4.4 North America Small Interfering RNA (siRNA) Therapeutics Sales and Growth Rate (2015-2020)
4.5 South America Small Interfering RNA (siRNA) Therapeutics Sales and Growth Rate (2015-2020)
4.6 Middle East & Africa Small Interfering RNA (siRNA) Therapeutics Sales and Growth Rate (2015-2020)
5 Europe Small Interfering RNA (siRNA) Therapeutics Market Size Categorized by Countries5.1 Europe Small Interfering RNA (siRNA) Therapeutics Sales, Revenue and Market Share by Countries
5.1.1 Europe Small Interfering RNA (siRNA) Therapeutics Sales by Countries (2015-2020)
5.1.2 Europe Small Interfering RNA (siRNA) Therapeutics Revenue by Countries (2015-2020)
5.1.3 Germany Small Interfering RNA (siRNA) Therapeutics Sales and Growth Rate (2015-2020)
5.1.4 UK Small Interfering RNA (siRNA) Therapeutics Sales and Growth Rate (2015-2020)
5.1.5 France Small Interfering RNA (siRNA) Therapeutics Sales and Growth Rate (2015-2020)
5.1.6 Russia Small Interfering RNA (siRNA) Therapeutics Sales and Growth Rate (2015-2020)
5.1.7 Italy Small Interfering RNA (siRNA) Therapeutics Sales and Growth Rate (2015-2020)
5.1.8 Spain Small Interfering RNA (siRNA) Therapeutics Sales and Growth Rate (2015-2020)5.2 Europe Small Interfering RNA (siRNA) Therapeutics Revenue (Value) by Manufacturers (2018-2020)
5.3 Europe Small Interfering RNA (siRNA) Therapeutics Sales, Revenue and Market Share by Type (2015-2020)
5.3.1 Europe Small Interfering RNA (siRNA) Therapeutics Sales Market Share by Type (2015-2020)
5.3.2 Europe Small Interfering RNA (siRNA) Therapeutics Revenue and Revenue Share by Type (2015-2020)5.4 Europe Small Interfering RNA (siRNA) Therapeutics Sales Market Share by Application (2015-2020)
6 Asia-Pacific Small Interfering RNA (siRNA) Therapeutics Market Size Categorized by Countries6.1 Asia-Pacific Small Interfering RNA (siRNA) Therapeutics Sales, Revenue and Market Share by Countries
6.1.1 Asia-Pacific Small Interfering RNA (siRNA) Therapeutics Sales by Countries (2015-2020)
6.1.2 Asia-Pacific Small Interfering RNA (siRNA) Therapeutics Revenue by Countries (2015-2020)
6.1.3 China Small Interfering RNA (siRNA) Therapeutics Sales and Growth Rate (2015-2020)
6.1.4 Japan Small Interfering RNA (siRNA) Therapeutics Sales and Growth Rate (2015-2020)
6.1.5 Korea Small Interfering RNA (siRNA) Therapeutics Sales and Growth Rate (2015-2020)
6.1.6 India Small Interfering RNA (siRNA) Therapeutics Sales and Growth Rate (2015-2020)
6.1.7 Southeast Asia Small Interfering RNA (siRNA) Therapeutics Sales and Growth Rate (2015-2020)
6.1.8 Australia Small Interfering RNA (siRNA) Therapeutics Sales and Growth Rate (2015-2020)6.2 Asia-Pacific Small Interfering RNA (siRNA) Therapeutics Sales and Revenue (Value) by Manufacturers (2018-2020)
6.3 Asia-Pacific Small Interfering RNA (siRNA) Therapeutics Sales, Revenue and Market Share by Type (2015-2020)
6.3.1 Asia-Pacific Small Interfering RNA (siRNA) Therapeutics Sales Market Share by Type (2015-2020)
6.3.2 Asia-Pacific Small Interfering RNA (siRNA) Therapeutics Revenue and Revenue Share by Type (2015-2020)6.4 Asia-Pacific Small Interfering RNA (siRNA) Therapeutics Sales and Market Share by Application (2015-2020)
7 North America Small Interfering RNA (siRNA) Therapeutics Market Size Categorized by Countries7.1 North America Small Interfering RNA (siRNA) Therapeutics Sales, Revenue and Market Share by Countries
7.1.1 North America Small Interfering RNA (siRNA) Therapeutics Sales by Countries (2015-2020)
7.1.2 North America Small Interfering RNA (siRNA) Therapeutics Revenue by Countries (2015-2020)
7.1.3 United States Small Interfering RNA (siRNA) Therapeutics Sales and Growth Rate (2015-2020)
7.1.4 Canada Small Interfering RNA (siRNA) Therapeutics Sales and Growth Rate (2015-2020)
7.1.5 Mexico Small Interfering RNA (siRNA) Therapeutics Sales and Growth Rate (2015-2020)7.2 North America Small Interfering RNA (siRNA) Therapeutics Revenue (Value) by Manufacturers (2018-2020)
7.3 North America Small Interfering RNA (siRNA) Therapeutics Sales, Revenue and Market Share by Type (2015-2020)
7.3.1 North America Small Interfering RNA (siRNA) Therapeutics Sales Market Share by Type (2015-2020)
7.3.2 North America Small Interfering RNA (siRNA) Therapeutics Revenue and Revenue Share by Type (2015-2020)7.4 North America Small Interfering RNA (siRNA) Therapeutics Sales Market Share by Application (2015-2020)
8 South America Small Interfering RNA (siRNA) Therapeutics Market Size Categorized by Countries8.1 South America Small Interfering RNA (siRNA) Therapeutics Sales, Revenue and Market Share by Countries
8.1.1 South America Small Interfering RNA (siRNA) Therapeutics Sales by Countries (2015-2020)
8.1.2 South America Small Interfering RNA (siRNA) Therapeutics Revenue by Countries (2015-2020)
8.1.3 Brazil Small Interfering RNA (siRNA) Therapeutics Sales and Growth Rate (2015-2020)8.2 South America Small Interfering RNA (siRNA) Therapeutics Revenue (Value) by Manufacturers (2018-2020)
8.3 South America Small Interfering RNA (siRNA) Therapeutics Sales, Revenue and Market Share by Type (2015-2020)
8.3.1 South America Small Interfering RNA (siRNA) Therapeutics Sales Market Share by Type (2015-2020)
8.3.2 South America Small Interfering RNA (siRNA) Therapeutics Revenue and Revenue Share by Type (2015-2020)8.4 South America Small Interfering RNA (siRNA) Therapeutics Sales Market Share by Application (2015-2020)
9 Middle East and Africa Small Interfering RNA (siRNA) Therapeutics Market Size Categorized by Countries9.1 Middle East and Africa Small Interfering RNA (siRNA) Therapeutics Sales, Revenue and Market Share by Countries
9.1.1 Middle East and Africa Small Interfering RNA (siRNA) Therapeutics Sales by Countries (2015-2020)
9.1.2 Middle East and Africa Small Interfering RNA (siRNA) Therapeutics Revenue by Countries (2015-2020)
9.1.3 GCC Countries Small Interfering RNA (siRNA) Therapeutics Sales and Growth Rate (2015-2020)
9.1.4 Turkey Small Interfering RNA (siRNA) Therapeutics Sales and Growth Rate (2015-2020)
9.1.5 Egypt Small Interfering RNA (siRNA) Therapeutics Sales and Growth Rate (2015-2020)
9.1.6 South Africa Small Interfering RNA (siRNA) Therapeutics Sales and Growth Rate (2015-2020)9.2 Middle East and Africa Small Interfering RNA (siRNA) Therapeutics Revenue (Value) by Manufacturers (2018-2020)
9.3 Middle East and Africa Small Interfering RNA (siRNA) Therapeutics Sales, Revenue and Market Share by Type
9.3.1 Middle East and Africa Small Interfering RNA (siRNA) Therapeutics Sales Market Share by Type (2015-2020)
9.3.2 Middle East and Africa Small Interfering RNA (siRNA) Therapeutics Revenue and Revenue Share by Type (2015-2020)9.4 Middle East and Africa Small Interfering RNA (siRNA) Therapeutics Sales Market Share by Application (2015-2020)
10 Global Small Interfering RNA (siRNA) Therapeutics Market Segment by Type10.1 Global Small Interfering RNA (siRNA) Therapeutics Revenue, Sales and Market Share by Type (2015-2020)
10.1.1 Global Small Interfering RNA (siRNA) Therapeutics Sales and Market Share by Type (2015-2020)
10.1.2 Global Small Interfering RNA (siRNA) Therapeutics Revenue and Market Share by Type (2015-2020)10.2 Liposome Based Systemic Therapy Sales Growth Rate and Price
10.2.1 Global Liposome Based Systemic Therapy Sales Growth Rate (2015-2020)
10.2.2 Global Liposome Based Systemic Therapy Price (2015-2020)10.3 Nanoparticle Based Systemic Therapy Sales Growth Rate and Price
10.3.1 Global Nanoparticle Based Systemic Therapy Sales Growth Rate (2015-2020)
10.3.2 Global Nanoparticle Based Systemic Therapy Price (2015-2020)10.4 Other Sales Growth Rate and Price
10.4.1 Global Other Sales Growth Rate (2015-2020)
10.4.2 Global Other Price (2015-2020)
11 Global Small Interfering RNA (siRNA) Therapeutics Market Segment by Application11.1 Global Small Interfering RNA (siRNA) TherapeuticsSales Market Share by Application (2015-2020)
11.2 Hospital Sales Growth Rate (2015-2020)
11.3 Research Institutions Sales Growth Rate (2015-2020)
11.4 Pharmaceutical and Biotechnology Companies Sales Growth Rate (2015-2020)
11.5 Academic Institutions Sales Growth Rate (2015-2020)
11.6 Other Sales Growth Rate (2015-2020)
12 Market Forecast for Small Interfering RNA (siRNA) Therapeutics12.1 Global Small Interfering RNA (siRNA) Therapeutics Revenue, Sales and Growth Rate (2020-2025)
12.2 Small Interfering RNA (siRNA) Therapeutics Market Forecast by Regions (2020-2025)
12.2.1 Europe Small Interfering RNA (siRNA) Therapeutics Market Forecast (2020-2025)
12.2.2 APAC Small Interfering RNA (siRNA) Therapeutics Market Forecast (2020-2025)
12.2.3 North America Small Interfering RNA (siRNA) Therapeutics Market Forecast (2020-2025)
12.2.4 South America Small Interfering RNA (siRNA) Therapeutics Market Forecast (2020-2025)
12.2.5 Middle East & Africa Small Interfering RNA (siRNA) Therapeutics Market Forecast (2020-2025)12.3 Small Interfering RNA (siRNA) Therapeutics Market Forecast by Type (2020-2025)
12.3.1 Global Small Interfering RNA (siRNA) Therapeutics Sales Forecast by Type (2020-2025)
12.3.2 Global Small Interfering RNA (siRNA) Therapeutics Market Share Forecast by Type (2020-2025)12.4 Small Interfering RNA (siRNA) Therapeutics Market Forecast by Application (2020-2025)
12.4.1 Global Small Interfering RNA (siRNA) Therapeutics Sales Forecast by Application (2020-2025)
12.4.2 Global Small Interfering RNA (siRNA) Therapeutics Market Share Forecast by Application (2020-2025)
13 Analysis of Small Interfering RNA (siRNA) Therapeutics Industry Key Manufacturers13.1 GE
13.1.1 Company Details
13.1.2 Product Information
13.1.3 GE Small Interfering RNA (siRNA) Therapeutics Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
13.1.4 Main Business Overview
13.1.5 GE News13.2 Horizon Discovery
13.2.1 Company Details
13.2.2 Product Information
13.2.3 Horizon Discovery Small Interfering RNA (siRNA) Therapeutics Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
13.2.4 Main Business Overview
13.2.5 Horizon Discovery News13.3 Thermo Scientific
13.3.1 Company Details
13.3.2 Product Information
13.3.3 Thermo Scientific Small Interfering RNA (siRNA) Therapeutics Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
13.3.4 Main Business Overview
13.3.5 Thermo Scientific News13.4 OPKO Health
13.4.1 Company Details
13.4.2 Product Information
13.4.3 OPKO Health Small Interfering RNA (siRNA) Therapeutics Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
13.4.4 Main Business Overview
13.4.5 OPKO Health News13.5 AInylam Pharmaceuticals
13.5.1 Company Details
13.5.2 Product Information
13.5.3 AInylam Pharmaceuticals Small Interfering RNA (siRNA) Therapeutics Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
13.5.4 Main Business Overview
13.5.5 AInylam Pharmaceuticals News13.6 Arrowhead Research
13.6.1 Company Details
13.6.2 Product Information
13.6.3 Arrowhead Research Small Interfering RNA (siRNA) Therapeutics Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
13.6.4 Main Business Overview
13.6.5 Arrowhead Research News
13.7 Sanofi Genzyme
13.7.1 Company Details
13.7.2 Product Information
13.7.3 Sanofi Genzyme Small Interfering RNA (siRNA) Therapeutics Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
13.7.4 Main Business Overview
13.7.5 Sanofi Genzyme News
13.8 Genecon Biotechnologies
13.8.1 Company Details
13.8.2 Product Information
13.8.3 Genecon Biotechnologies Small Interfering RNA (siRNA) Therapeutics Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
13.8.4 Main Business Overview
13.8.5 Genecon Biotechnologies News
13.9 Arbutus Biopharma
13.9.1 Company Details
13.9.2 Product Information
13.9.3 Arbutus Biopharma Small Interfering RNA (siRNA) Therapeutics Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
13.9.4 Main Business Overview
13.9.5 Arbutus Biopharma News13.10 Silent Therapeutics
13.10.1 Company Details
13.10.2 Product Information
13.10.3 Silent Therapeutics Small Interfering RNA (siRNA) Therapeutics Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
13.10.4 Main Business Overview
13.10.5 Silent Therapeutics News
13.11 Sylentis
13.11.1 Company Details
13.11.2 Product Information
13.11.3 Sylentis Small Interfering RNA (siRNA) Therapeutics Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
13.11.4 Main Business Overview
13.11.5 Sylentis News
14 Research Findings and Conclusion
15 Appendix
-
The Global Small Interfering RNA (siRNA) Therapeutics Market has been segregated into various crucial divisions including applications, types, and regions. Each market segment is intensively studied in the report contemplating its market acceptance, worthiness, demand, and growth prospects. The segmentation analysis will help the client to customize their marketing approach to have a better command of each segment and to identify the most prospective customer base.
Report Objectives / Segmentation Covered :
By Companies / players:
By Regions:
By Type:
By Application:
Frequently asked questions(FAQ's):
A large number of Global Global Small Interfering RNA (siRNA) Therapeutics players are focusing on individualized and innovative technologies that will provide the necessary impetus for profit and growth in the coming years.
It is expected that the Global Small Interfering RNA (siRNA) Therapeutics Market will reach USD XX million by 2029.
A handful of disruptive trends, nevertheless, will have a contradictory and significant impact on the development of the Global Small Interfering RNA (siRNA) Therapeutics Market as well as its distribution among its players
The majority of data for the Global Small Interfering RNA (siRNA) Therapeutics Industry is gathered through primary sources, which include interviews and surveys with industry experts from the core and related industries involved in the supply chain. Secondary sources, such as SEC filings, annual reports, whitepapers, and press releases, are also used.
